Yi Long Selected Research

Yi Long Research Topics

Disease

10	Neoplasms (Cancer) 02/2022 - 01/2010
3	Obesity 01/2022 - 02/2017
3	Critical Illness (Critically Ill) 01/2019 - 06/2008
2	Wounds and Injuries (Trauma) 10/2021 - 01/2021
2	Carcinogenesis 03/2021 - 05/2012
2	Hemorrhage 02/2021 - 06/2020
2	Body Weight (Weight, Body) 01/2021 - 07/2014
2	Fibrosis (Cirrhosis) 06/2020 - 08/2011
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 03/2017
2	Inflammation (Inflammations) 02/2018 - 07/2014
2	Breast Neoplasms (Breast Cancer) 05/2012 - 01/2010
1	COVID-19 06/2022
1	Leukemia 02/2022
1	Rotator Cuff Injuries 01/2022
1	Shock 11/2021
1	ST Elevation Myocardial Infarction 11/2021
1	Chronic Renal Insufficiency 11/2021
1	Hematoma 10/2021
1	Infections 10/2021
1	Pain (Aches) 04/2021
1	Bursitis (Adhesive Capsulitis) 04/2021
1	Sarcoma (Soft Tissue Sarcoma) 03/2021
1	Carcinoma (Carcinomatosis) 03/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2021
1	Hypersensitivity (Allergy) 01/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2021
1	Insulin Resistance 01/2021
1	Keloid 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2020
1	Liver Neoplasms (Liver Cancer) 12/2020
1	Stroke (Strokes) 11/2020
1	Brain Ischemia (Cerebral Ischemia) 05/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Lymphatic Metastasis 01/2020
1	Euthyroid Sick Syndromes (Euthyroid Sick Syndrome) 01/2019
1	Osteosarcoma (Osteogenic Sarcoma) 02/2018
1	Experimental Arthritis 02/2018
1	Chondrosarcoma 01/2017
1	Osteoarthritis 03/2015

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2017
3	MicroRNAs (MicroRNA)IBA 03/2021 - 05/2012
2	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2022
2	NitrogenIBA 11/2021 - 12/2016
2	CreatinineIBA 11/2021 - 03/2017
2	Hemoglobins (Hemoglobin)IBA 11/2021 - 02/2021
2	Long Noncoding RNAIBA 03/2021 - 01/2020
2	Autophagy-Related ProteinsIBA 01/2021 - 12/2019
2	Biological ProductsIBA 01/2021 - 01/2011
2	AlbuminsIBA 06/2020 - 03/2017
2	Cystatin CIBA 01/2019 - 03/2017
2	Arsenic Trioxide (Trisenox)FDA Link 01/2011 - 12/2008
1	Nucleic AcidsIBA 06/2022
1	acivicin (AT 125)IBA 02/2022
1	hemoglobin P (Hb P)IBA 11/2021
1	Urea (Carbamide)FDA LinkGeneric 11/2021
1	fms-Like Tyrosine Kinase 3IBA 03/2021
1	Messenger RNA (mRNA)IBA 03/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021
1	Competitive Endogenous RNAIBA 03/2021
1	Parathyroid Hormone (Parathormone)IBA 03/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	punicalaginIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	GlycolipidsIBA 01/2021
1	CollagenIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	LipidsIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Proline (L-Proline)FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	SaltsIBA 01/2021
1	Abscisic AcidIBA 01/2021
1	TanninsIBA 01/2021
1	Beclin-1IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Sufentanil (Sufenta)FDA LinkGeneric 12/2020
1	Hydromorphone (Dilaudid)FDA LinkGeneric 12/2020
1	Immunologic Factors (Immunomodulators)IBA 12/2020
1	PeroxidesIBA 05/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2019
1	Thyroid HormonesIBA 01/2019
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2019
1	oxymatrineIBA 02/2018
1	Quinolizidine AlkaloidsIBA 02/2018
1	Hexosaminidases (Hexosaminidase)IBA 03/2017
1	Nonsense Codon (Nonsense Mutation)IBA 02/2017
1	rhodiolosideIBA 01/2017
1	CytokinesIBA 07/2014

Therapy/Procedure

3	Oral Administration 02/2022 - 01/2010
1	Sutures (Suture) 01/2022
1	Resistance Training 01/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 11/2021
1	Erythrocyte Transfusion 11/2021
1	Suture Anchors 10/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 04/2021
1	Operative Time 02/2021
1	Analgesia 12/2020
1	Activities of Daily Living (ADL) 11/2020
1	Hepatectomy 01/2020